Shilpa Medicare surges on receiving EIR from USFDA for Telangana facility

19 Mar 2018 Evaluate

Shilpa Medicare is currently trading at Rs. 475.60, up by 20.15 points or 4.42% from its previous closing of Rs. 455.45 on the BSE.

The scrip opened at Rs. 467.20 and has touched a high and low of Rs. 488.45 and Rs. 467.20 respectively. So far 12,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 748.95 on 12-Apr-2017 and a 52 week low of Rs. 401.00 on 08-Mar-2018.

Last one week high and low of the scrip stood at Rs. 488.45 and Rs. 431.55 respectively. The current market cap of the company is Rs. 3,810.00 crore.

The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 31.79% and 14.40% respectively.

Shilpa Medicare has received Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its formulations manufacturing facility (SEZ unit) located at Jadcherla, Telangana, India which was inspected between November 11 and November 30, 2017. USFDA has determined that the inspection classification of this facility is VAI and accordingly EIR issued.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.


Shilpa Medicare Share Price

319.85 -0.65 (-0.20%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×